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Edited by Veli-Pekka LehtoAbstract Mesenchymal stem cells (MSC) transplantation has
been shown to decrease ﬁbrosis in the heart; however, whether
MSC directly inﬂuence the function of cardiac ﬁbroblasts
(CFB) remains unknown. MSC-conditioned medium signiﬁ-
cantly attenuated proliferation of CFB compared with CFB-con-
ditioned medium. MSC-conditioned medium upregulated
antiproliferation-related genes such as elastin, myocardin and
DNA-damage inducible transcript 3, whereas CFB-conditioned
medium upregulated proliferation-related genes such as alpha-
2-macrogrobulin and v-kit Hardy–Zuckerman 4 feline sarcoma
viral oncogene homolog. MSC-conditioned medium signiﬁcantly
downregulated type I and III collagen expression, and signiﬁ-
cantly suppressed type III collagen promoter activity. MSC
may exert paracrine anti-ﬁbrotic eﬀects at least in part through
regulation of CFB proliferation and collagen synthesis.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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activity1. Introduction
Mesenchymal stem cells (MSC) can diﬀerentiate into a vari-
ety of cell types including cardiomyocytes and vascular endo-
thelial cells, and can be easily isolated from bone marrow
and expanded in culture [1]. These features make MSC an
attractive therapeutic tool for cardiovascular disease. We and
others have previously demonstrated that MSC transplanta-
tion caused signiﬁcant improvement in hindlimb ischemia [2],
myocardial infarction [3,4], dilated cardiomyopathy [5] and
acute myocarditis [6]. MSC transplantation has been shownAbbreviations: MSC, mesenchymal stem cell; CFB, cardiac ﬁbroblast;
MMP, matrix metalloproteinase; qRT-PCR, quantitative real-time
reverse-transcription polymerase chain reaction; Gapdh, glyceralde-
hyde 3-phosphate dehydrogenase; A2m, alpha-2-macroglobulin; Kit,
v-kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homolog;
Catna1, catenin alpha 1; Rarb, retinoic acid receptor beta; Eln, elastin;
Myocd, myocardin; Ddit3, DNA-damage inducible transcript 3
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doi:10.1016/j.febslet.2007.07.028to result in cardiac repair and protection at least in part
through paracrine actions such as angiogenic, anti-apoptotic,
and anti-inﬂammatory eﬀects [2,3,5–10]. In addition, it has
been demonstrated in animal models that MSC transplanta-
tion decreases ﬁbrosis in the heart [5] and other organs such
as lung [11,12], liver [13,14] and kidney [15]. However, whether
transplanted MSC directly inﬂuence the function of cardiac
ﬁbroblasts (CFB) remains unknown.
Deposition of collagen ﬁbers in the myocardial interstitium
occurs in the remodeling process seen in a variety of cardiovas-
cular diseases, and CFB are predominantly involved in the
maintenance of extracellular matrix such as types I and III col-
lagen by cell proliferation, collagen synthesis and degradation
[16]. Collagen synthesis is regulated by ﬁbrogenic factors, and
collagen degradation is mediated by members of the matrix
metalloproteinases (MMPs), which are also regulated by tissue
inhibitors of metalloproteinases [17,18].
Thus, we investigated the paracrine eﬀects of MSC on (1)
CFB proliferation, (2) collagen synthesis and (3) collagen deg-
radation in vitro.2. Materials and methods
2.1. Cell culture and collection of conditioned medium
Isolation and expansion of MSC were performed as described previ-
ously [2]. Brieﬂy, bone marrow cells were isolated from male Lewis rats
weighing 220–250 g by ﬂushing out the femoral and tibial cavities with
phosphate-buﬀered saline, and cultured in standard medium: a-mini-
mal essential medium, 10% fetal bovine serum, 100 U/ml penicillin
and 100 lg/ml streptomycin. Five days after plating, non-adherent cells
were removed, and adherent cells were further propagated for 4–5 pas-
sages. These cells were previously demonstrated to be positive for
CD29 and CD90 surface markers, and negative for CD34 and CD45
[5]. The Animal Care Committee of the National Cardiovascular Cen-
ter approved the experimental protocol.
Primary CFB were obtained as described previously with modiﬁca-
tion [19]. Brieﬂy, after heparinization by intraperitoneal injection of
1000 U/kg heparin sodium, the heart was rapidly excised, and pulmon-
ary, connective and other non-cardiac tissues were removed. The heart
was then mounted on the cannula of a modiﬁed Langendorﬀ apparatus
and perfused with buﬀer containing 0.75 mg/ml collagenase type I
(Worthington, Lakewood, NJ), 0.5 mg/ml hyaluronidase (Sigma–Al-
drich, St. Louis, MO) and 1% bovine serum albumin (fraction V,
ICN, Aurora, OH), in a recirculating fashion for 3 h. After perfusion,
the heart was removed from the perfusion apparatus, and the atrium
was removed and gently minced. CFB were gravitationally separated
from cardiomyocytes, and cultured in standard medium.
Conditioned mediumwas collected fromMSC and CFB after the sec-
ond passage of 3 · 105 cells cultured in standard medium for 48 h, and
ﬁltered through a 0.22 lm-ﬁltration unit (Millipore, Bedford, MA).blished by Elsevier B.V. All rights reserved.
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We investigated the paracrine eﬀects of MSC on ﬁbroblast prolifer-
ation in vitro. Experiments were carried out using cells derived from
ﬁve passages. CFB were plated on 96-well plates (4 · 103 cells/well).
After 24 h, the medium was changed to conditioned medium obtained
from MSC or CFB culture for 48 h. After 48 h, the cellular level of 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophe-
nyl)-2H-tetrazolium (MTS), indicative of the mitochondrial function
of living cells and cell viability, was measured with a CellTiter96
AQueous One Solution Kit (Promega, Madison, WI) and a Microplate
Reader (490 nm, Bio-Rad, Hercules, CA).
2.3. Microarray analysis
Total RNA was extracted from cells using an RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instruc-
tions. RNA was quantiﬁed by spectrometry and the quality conﬁrmed
by gel electrophoresis. Microarray analysis was performed as described
previously [20]. In brief, double-stranded cDNA was synthesized from
4 lg total RNA, and in vitro transcription was performed to produce
biotin-labeled cRNA using GeneChip One-Cycle Target Labeling and
Control Reagents (Aﬀymetrix, Santa Clara, CA) according to the man-
ufacturer’s instructions. After fragmentation, 10 lg cRNA was hybrid-
ized with GeneChip Rat Genome 230 2.0 Array (Aﬀymetrix)
containing 31099 genes. GeneChips were then scanned in a GeneChip
Scanner 3000 (Aﬀymetrix). Normalization, ﬁltering, and Gene Ontol-
ogy analysis of the data were performed with GeneSpring GX 7.3.1
software (Agilent Technologies, Palo Alto, CA). The raw data from
each array were normalized as follows; each CEL ﬁle was preprocessed
with Robust Multichip Average (RMA), and each measurement for
each gene was divided by the 80th percentile of all measurements.
Genes with an at least 1.8-fold change were then selected.
2.4. Quantitative real-time reverse-transcription polymerase chain
reaction (qRT-PCR)
One microgram of total RNA was reverse-transcribed into cDNA
using a Quantitect Reverse Transcription Kit (Qiagen). PCR ampliﬁca-
tion was performed in 50 ll containing 1 ll cDNA and 25 ll Power
SYBR Green PCR Master Mix (Applied Biosystems, Foster City,
CA). Glyceraldehyde 3-phosphate dehydrogenase (Gapdh) mRNA
ampliﬁed from the same samples served as an internal control. Primers
used in qRT-PCR analysis were as follows: Col1a1: forward,
5 0-TCAAGATGGTGGCCGTTAC-3 0, reverse, 5 0-CTGCGGATGT-
TC-TCAATCTG-3 0, Col3a1: forward, 5 0-CGAGATTAAAGCAA-
GAGGAA-30, reverse, 50-GAGGCTTCTTTACATACCAC-30, Gapdh:
forward, 5 0-TGAAGGTCGGTGTCAACGGATTTGGC-3 0, reverse,
5 0-CATGTAGGCCATGAGGTCCACCAC-3 0. After an initial dena-
turation at 95C for 10 min, a two-step cycle procedure was used
(denaturation at 95 C for 15 s, annealing and extension at 60 C for
1 min) for 40 cycles in a 7700 sequence detector (Applied Biosystems).
Gene expression levels were normalized according to that of Gapdh.
The data were analyzed with Sequence Detection Systems software
(Applied Biosystems).
2.5. Transient transfection and reporter gene assay
Transient transfection and subsequent reporter gene assay were per-
formed as described previously with modiﬁcation [21]. The Col1a1
clones containing the promoter fragments 1685/+68Luc and 96/
+68Luc were provided by Dr. H. Yoshioka of Oita University, Japan.
CFB were plated at a density of 1 · 104 cells in 96-well plates with
100 ll culture medium. After incubation for 24 h at 37 C, cells were
transfected with 200 ng luciferase plasmid DNA plus 10 ng Renilla
phRL-TK vector (Promega, Madison, WI) as an internal control,
using lipofectamine2000 (Invitrogen). Six hours after transfection, cells
were rinsed with PBS, fed with conditioned medium obtained from
MSC or CFB culture, and then further cultured for 48 h. Reporter
gene assay was performed using the Dual-Glo Luciferase reporter as-
say system (Promega), and the luminescence intensity was measured
using a microplate reader (Dia-Iatron, Tokyo, Japan), according to
the manufacturer’s protocol. The transcription activity was normalized
according to Renilla luciferase activity.
2.6. Collagenase activity
Collagenase activity assay was performed using a collagenase assay
kit (Chondrex, Redmond, WA) following the manufacturer’s instruc-tions. CFB were cultured in CFB- or MSC-conditioned medium with
ﬂuorescein isothiocyanate-labeled type I collagen for 48 h, and de-
graded collagen was extracted by denaturation, proteinase treatment
and centrifugation. Fluorescence intensity was measured using a ﬂuo-
rometer (Tecan, Salzburg, Austria) at excitation/emission of 485/
535 nm.2.7. Statistical analysis
Data were expressed as means ± standard error (S.E.). Comparisons
of parameters among groups were made by one-way ANOVA, fol-
lowed by Newman–Keuls’ test. Diﬀerences were considered signiﬁcant
at P < 0.05.3. Results
3.1. Eﬀect of MSC-conditioned medium on proliferation of CFB
To investigate the eﬀect of MSC-conditioned medium on
CFB proliferation, we cultured CFB in standard medium,
CFB- or MSC-conditioned medium for 48 h, and MTS assay
was performed. Viable cell number was signiﬁcantly larger
when CFB were cultured in CFB-conditioned medium com-
pared with standard medium, whereas this increase was not
observed when CFB were cultured in MSC-conditioned med-
ium (Fig. 1A, B). These results suggest that MSC attenuates
proliferation of CFB through paracrine actions.3.2. Eﬀect of MSC-conditioned medium on expression of genes
involved in cell proliferation in CFB
We next performed microarray analysis to examine the eﬀect
of MSC-conditioned medium on the expression of genes in-
volved in the regulation of cell proliferation in CFB. Highly
expressed genes in CFB cultured in CFB-conditioned medium
(>1.8-fold) included positive regulators for cell proliferation
such as alpha-2-macroglobulin (A2m) and v-kit Hardy–Zuck-
erman 4 feline sarcoma viral oncogene homolog (Kit), as well
as negative regulators for cell proliferation such as catenin al-
pha 1 (Catna1) and retinoic acid receptor beta (Rarb). On the
other hand, CFB cultured in MSC-conditioned medium highly
expressed negative regulators for cell proliferation such as elas-
tin (Eln), myocardin (Myocd) and DNA-damage inducible
transcript 3 (Ddit3) (Table 1).3.3. Eﬀect of MSC-conditioned medium on collagen gene
expression
To investigate the eﬀect of MSC-conditioned medium on
collagen gene expression, we performed qRT-PCR on types I
and III collagen genes (Col1a1 and Col3a1, respectively) in
CFB. Expression of Col1a1 and Col3a1 genes was signiﬁcantly
upregulated when CFB were cultured in CFB-conditioned
medium in comparison to standard medium. However, this in-
crease was signiﬁcantly attenuated when CFB were cultured in
MSC-conditioned medium (Fig. 2A, B).3.4. Eﬀect of MSC-conditioned medium on collagen gene
promoter activity
To investigate the eﬀect of MSC-conditioned medium on
Col3a1 gene promoter activity, we performed reporter gene as-
say in CFB. We prepared 1685/+68Luc and 96/+68Luc
constructs (Fig. 3A), as the 96 to 34 region has been re-
ported to be fundamental for Col3a1 gene transcription [21].
The activity of 1685/+68Luc was signiﬁcantly higher in
Table 1
Expression of genes involved in regulation of cell proliferation
(>1.8-fold)
Gene name Action on cell
proliferation
Fold change
Genes highly expressed in
CFB-conditioned medium
catenin, alpha 1 (Catna1) Neg 2.3
retinoic acid receptor, beta
(Rarb)
Neg 2.1
alpha-2-macroglobulin
(A2m)
Pos 2.0
v-kit Hardy–Zuckerman 4
feline sarcoma viral
oncogene homolog (Kit)
Pos 1.8
Genes highly expressed in
MSC-conditioned medium
elastin (Eln) Neg 3.8
myocardin (Myocd) Neg 1.9
DNA-damage inducible
transcript 3 (Ddit3)
Neg 1.8
Fig. 1. Eﬀect of MSC-conditioned medium on CFB proliferation MTS assay (A) and representative photographs (B) of CFB after 48 h of culture in
the indicated medium. SM, standard medium; CM, conditioned medium. Values are means ± S.E. *P < 0.05 vs SM, P < 0.05 vs CFB-CM.
Fig. 2. Eﬀect of MSC-conditioned medium on collagen gene expres-
sion (A) Quantitative RT-PCR for Col1a1 expression in CFB after
48 h of culture in the indicated medium. (B) Quantitative RT-PCR for
Col3a1 expression in CFB after 48 h of culture in the indicated
medium. SM, standard medium; CM, conditioned medium. Values are
means ± S.E. *P < 0.05 vs SM, P < 0.05 vs CFB-CM.
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whereas it was markedly decreased in MSC-conditioned med-
ium (Fig. 3B). However, the activity of 96/+68Luc was not
aﬀected in either CFB- or MSC-conditioned medium. These
results suggest that MSC-conditioned medium inhibits Col3a1
gene transcription through regulation of the 1685 to 96
promoter region.
3.5. Eﬀect of MSC-conditioned medium on collagenase activity
We ﬁnally investigated the eﬀect of MSC-conditioned
medium on collagen degradation. Type I collagenase activity
was markedly higher in CFB-conditioned medium than in
standard medium; however, MSC-conditioned medium hadas high collagenase activity as CFB-conditioned medium
(Fig. 4).
Fig. 3. Eﬀect of MSC-conditioned medium on type III collagen gene promoter activity (A) Schematic illustration of 5 0-deletion constructs of the
Col3a1 promoter. (B) Luﬁcerase activity in CFB after 48 hours of transfection of reporter plasmids and culture in the indicated medium. All
constructs were co-transfected with the phRL-TK vector as an internal control for transfection eﬃciency. SM, standard medium; CM, conditioned
medium. Values are means ± S.E. *P < 0.05 vs SM, P < 0.05 vs CFB-CM.
Fig. 4. Eﬀect of MSC-conditioned medium on collagenase activity
Type I collagenase activity of the indicated medium. SM, standard
medium; CM, conditioned medium. Values are means ± S.E. *P < 0.05
vs SM.
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In this study, we focused on the paracrine eﬀects of MSC on
CFB in vitro, and demonstrated that MSC-conditioned med-
ium: (1) attenuated CFB proliferation, (2) regulated expression
of several genes involved in CFB proliferation, (3) transcrip-
tionally inhibited type I and III collagen gene expression in
CFB, and (4) had comparable collagenase activity to that of
CFB-conditioned medium.
We and others have previously demonstrated that MSC
mediate pleiotropic eﬀects by secreting a large number of
growth factors, anti-apoptotic factors and cytokines [2,3,5–
10]. In addition, we have recently reported that MSC trans-
plantation improved cardiac function at least in part through
an anti-ﬁbrotic eﬀect in a rat model of dilated cardiomyopathy
and acute myocarditis [5,6], and also demonstrated that the
highly expressed genes in cultured MSC included a number
of molecules involved in biogenesis of extracellular matrix such
as collagens, MMPs, serine proteases and serine protease
inhibitors [20]. These results suggest that transplanted MSC
may inhibit the ﬁbrogenic process through paracrine actions.
In the present study, CFB proliferation was slower when
they were cultured in MSC-conditioned medium than in
CFB-conditioned medium, and microarray analysis demon-
strated that the expression levels of several genes involved in
cell proliferation were diﬀerently regulated. Out of four highly
expressed genes in CFB cultured in CFB-conditioned medium,two genes (A2m and Kit) are known to positively regulate cell
proliferation, whereas the other two genes (Catna1 and Rarb)
are known to be negative regulators. Catna1 encodes a-catenin
which interacts with cadherin, a cell adhesion molecule, and
targeted deletion of Catna1 in either the skin or in neuronal
progenitor cells leads to hyperproliferation [22]. Rarb encodes
a member of retinoic acid receptors, and regulated cell growth
and diﬀerentiation in a variety of cells [23]. A2m encodes a
plasma proteinase inhibitor [24], and induces macrophage pro-
liferation through cAMP-dependent signaling [25]. Kit encodes
c-kit protein, a tyrosine kinase receptor for stem cell factor,
and ectopic expression of c-kit in ﬁbroblasts induces tumori-
genesis [26]. On the other hand, three negative regulators of
cell proliferation were upregulated in CFB cultured in MSC-
conditioned medium. Eln encodes a polymer of a precursor
protein (tropoelastin), and impaired elastogenesis coincides
with increased cell proliferation [27]. Mycd encodes a tran-
scription factor important for smooth muscle and cardiac mus-
cle development, and inactivation of Mycd in ﬁbroblasts
increases their proliferative potential [28]. Ddit3 belongs to
the CCAAT/enhancer binding protein family of transcription
factors, and exogenous Ddit3 is capable of inducing growth ar-
rest and apoptosis [29]. Taking these ﬁndings together, MSC
may negatively regulate CFB proliferation by controlling these
factors, although the precise mechanism remains to be eluci-
dated.
Types I and III collagen are the major ﬁbrillar collagen pro-
duced by CFB, and the expression of collagen genes is regu-
lated at the transcriptional and post-transcriptional levels
[30]. It has been suggested that an initial mesh of type III col-
lagen forms the scaﬀold for subsequent deposition of large,
highly aligned type I collagen ﬁbers at the ﬁbrotic phase after
myocardial infarction [31]. In the present study, the expression
of Col1a1 as well as Col3a1 was downregulated when CFB
were cultured in MSC-conditioned medium. This result is con-
sistent with a recent study by Guo et al., which demonstrated
that MSC transplantation in a rat model of myocardial infarc-
tion inhibited deposition of types I and III collagen [32].
Although the transcriptional mechanism of the Col3a1 gene
is not entirely characterized, our in vitro experiments suggest
that, in comparison to CFB-conditioned medium, MSC-condi-
tioned medium may be rich in humoral factors that can inac-
tivate transcription, or poor in humoral factors that can
activate transcription, of Col3a1.
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ity are known to be elevated during the necrotic phase of in-
farct healing, and are involved in disruption of the collagen
network [33]. In the present study, type I collagenase activity
of MSC-conditioned medium was as high as that of CFB-con-
ditioned medium. Type I collagen is a substrate for MMP-1,
-2, -8 and -13, and the mechanisms involved in the diﬀerential
regulation of the various collagen types during cardiac ﬁbrosis
appear to be complex and diverse [34]. However, our results
imply that MSC have equivalent paracrine eﬀects on type I col-
lagenase activity to those of CFB.
In conclusion, MSC exerted paracrine anti-ﬁbrotic eﬀects at
least in part through regulation of CFB proliferation and tran-
scriptional downregulation of types I and III collagen synthe-
ses. These features of MSC may be beneﬁcial for the treatment
of heart failure in which ﬁbrotic changes are involved.Acknowledgements: This work was supported by research grants for
Cardiovascular Disease (18C-1 and 19C-7) and Human Genome Tis-
sue Engineering 009 from the Ministry of Health, Labour and Welfare,
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